Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical prediction models for inhibitor development in severe hemophilia A.

Journal of thrombosis and haemostasis : JTH - 1 Jul 2009

van den Berg H M, Chalmers E A

Abstract excerpt

Clinical prediction models for factor VIII inhibitor development may potentially facilitate the identification of patients at high risk of this complication. In particular, recognition of early intensive FVIII replacement therapy as a significant risk factor for inhibitor development has defined...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Autoantibodies
Share to Data Collection
Share to Factor VIII

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Predisposition to Disease

Share to Hemophilia A

Share to Prognosis

Share to Risk Factors

Source

Identifiers

PMID: 19630778
DOI: 10.1111/j.1538-7836.2009.03437.x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-19630778-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical prediction models for inhibitor development in severe hemophilia A.PMID 19630778Read ↗

Performance of a clinical risk prediction model for inhibitor formation in severe haemophilia A.Semantic proximity Read ↗

Improved prediction of inhibitor development in previously untreated patients with severe haemophilia A.Semantic proximity Read ↗

Prediction of inhibitors in hemophilia.Semantic proximity Read ↗

Understanding inhibitor development in haemophilia A: towards clinical prediction and prevention strategies.Semantic proximity Read ↗

Inhibitor Risk Stratification and Individualized Treatment in Patients With Nonsevere Hemophilia A: A Single-Institution Practice Audit.Semantic proximity Read ↗

Prevention and prediction of inhibitor risk.Semantic proximity Read ↗

Inhibitor development in hemophiliacs: the roles of genetic versus environmental factors.Semantic proximity Read ↗

Risk Factors for the Progression from Low to High Titres in 260 Children with Severe Haemophilia A and Newly Developed Inhibitors.Semantic proximity Read ↗

Incidence and risk factors for inhibitor development in previously untreated severe haemophilia A patients born between 2005 and 2010.Semantic proximity Read ↗

Environmental and genetic factors influencing inhibitor development.Semantic proximity Read ↗

Genetic risk stratification to reduce inhibitor development in the early treatment of hemophilia A: a SIPPET analysis.Semantic proximity Read ↗

Treatment related factors and inhibitor development in children with severe haemophilia A.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.